Jaguar Health reports Q2 2026 results, targets MVID NDA submission in Q2 2027Aug 19Quarterly updateJaguar Health, Inc.
Jaguar Health's Napo signs new crofelemer supply deal with Alivus after 2020 pact expiredJul 14PartnershipcrofelemerJaguar Health, Inc.
Sign inSign in